Wide Rande of resources on complex issues

We offer a wide range of resources on complex issues that impact all people with chronic conditions. Resources include member-specific services, frequent meetings and events, publications, and comments on rules and legislation.

The FDA’s Sentinel System Monitors Use, Safety, and Effectiveness of Medical Products

The FDA’s Sentinel System Monitors Use, Safety, and Effectiveness of Medical Products By Aimee Lee Russell, Associate, Programs On Wednesday, Aug. 21, Danijela Stojanovic, PharmD,

Read More

Getting to Know: Katie Soisson, Senior Associate, Operations and Meetings

Following is a Q&A to get to know Katie Soisson, Senior Associate, Operations and Meetings, who has been with the NHC since 2017. Putting Patients

Read More

The Sentinel System— An Overview of FDA’s Tools for Assessing Medical Product Safety and Gathering Real-World Evidence

The Sentinel System— An Overview of FDA’s Tools for Assessing Medical Product Safety and Gathering Real-World Evidence August 21, 2019 – This webinar provides an

Read More

Member Spotlight: Caregiver Action Network

By Katherine Scott, Senior Manager, Membership Services and Certifications Caregiver Action Network (CAN) is the nation’s leading family caregiver organization working to improve the quality of

Read More

NHC CEO Marc Boutin on Patients as Partners in Innovation, Education, and More at eyeforpharma

By Christina Howerton, Manager, Communications and New Media In April, National Health Council Chief Executive Marc Boutin, JD, participated in a fireside chat with Percival

Read More

NHC Comments on CMS Request for Information: Reducing Administrative Burden to Put Patients over Paperwork

The National Health Council (NHC) appreciates the opportunity to respond to the Centers for Medicare & Medicaid Services’ (CMS’) Request for Information entitled “Reducing Administrative

Read More

Registration Now Open: 2019 Science of Patient Engagement Symposium

By Silke Schoch, Senior Associate, Programs The National Health Council (NHC) is excited to welcome research leaders, and anyone interested in the science of patient

Read More

NHC Comment Letter: Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria, Enrollment Practices, and Trial Designs—Guidance for Industry

By Maddie Mason, Associate, Policy The U.S. Food and Drug Administration (FDA) released draft guidance for industry titled “Enhancing the Diversity of Clinical Trial Populations

Read More

NHC Comments on FDA’s Draft Guidance on Enhancing the Diversity of Clinical Trial Populations

The National Health Council (NHC) appreciates the opportunity to provide comments on the Food and Drug Administration’s (FDA’s) draft guidance on Enhancing the Diversity of

Read More